15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2026 | $179M | -$57M | 28.1% | -32.8% | -198.0% | -70.6% | -$33M | — | $21M |
| 2025 | $227M | -$6M | 30.5% | -0.7% | -7.4% | -4.2% | -$395000 | — | $55M |
| 2024 | $274M | -$7M | 30.9% | -3.0% | -7.7% | -4.4% | -$194000 | — | $55M |
| 2023 | $248M | $5M | 30.9% | 2.4% | 4.7% | 3.1% | $23M | — | $104M |
| 2022 | — | $19M | — | — | 15.2% | 10.4% | $17M | — | $111M |
| 2021 | — | $24M | — | — | 19.1% | 12.8% | $38M | — | $119M |
| 2020 | — | $26M | — | — | 21.5% | 16.6% | $37M | — | $104M |
| 2019 | — | $38M | — | — | 28.0% | 24.4% | $45M | — | $101M |
| 2018 | — | $37M | — | — | 32.2% | 27.7% | $37M | — | $78M |
| 2017 | — | $24M | — | — | 25.5% | 21.1% | $37M | — | $59M |
| 2016 | — | $21M | — | — | 24.7% | 22.8% | $923000 | — | $38M |
| 2015 | — | $17M | — | — | 23.1% | 21.1% | — | — | $36M |
| 2014 | — | $18M | — | — | 25.6% | 22.9% | — | — | $18M |
| 2013 | — | $17M | — | — | 26.8% | 23.5% | — | — | $18M |
| 2012 | — | $17M | — | — | 20.5% | 18.3% | — | — | $47M |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $41M | -$6M | 27.6% | -15.2% | -26.7% | -9.6% | -$8M | — | $13M |
| Mar '26 | $43M | -$4M | 32.6% | -13.3% | -14.0% | -5.0% | -$5M | — | $21M |
| Dec '25 | $41M | -$11M | 23.3% | -25.7% | -32.2% | -12.0% | -$9M | — | $27M |
| Sep '25 | $44M | -$9M | 28.0% | -18.9% | -19.8% | -8.5% | -$5M | — | $36M |
| Jun '25 | $51M | -$34M | 28.1% | -66.7% | -66.3% | -31.1% | -$14M | — | $41M |
| Mar '25 | $51M | -$12M | 29.9% | -11.9% | -13.7% | -7.8% | $5M | — | $55M |
| Dec '24 | $52M | -$707000 | 31.0% | -0.9% | -0.7% | -0.5% | -$2M | — | $50M |
| Sep '24 | $58M | $2M | 32.3% | 1.0% | 2.4% | 1.6% | $6M | — | $52M |
| Jun '24 | $66M | $4M | 28.8% | 6.6% | 4.0% | 2.5% | -$9M | — | $46M |
| Mar '24 | $60M | -$5M | 40.8% | -6.4% | -5.2% | -3.0% | $6M | — | $55M |
| Dec '23 | $64M | -$2M | 30.5% | -4.8% | -2.0% | -1.2% | -$4M | — | $49M |
| Sep '23 | $69M | $715000 | 30.6% | 1.3% | 0.7% | 0.4% | -$2M | — | $53M |
| Jun '23 | $78M | -$1M | 28.8% | -2.7% | -1.1% | -0.6% | -$591000 | — | $62M |
| Mar '23 | $60M | -$216000 | 31.6% | -0.4% | -0.2% | -0.1% | $8M | — | $104M |
| Dec '22 | $57M | -$212000 | 29.0% | -1.3% | -0.2% | -0.1% | $12M | — | $102M |
| Sep '22 | $63M | $3M | 31.9% | 5.9% | 2.1% | 1.7% | -$3M | — | $97M |
| Jun '22 | $67M | $3M | 31.0% | 5.2% | 2.0% | 1.7% | $5M | — | $105M |
| Mar '22 | — | $6M | — | — | 4.5% | 3.1% | $8M | — | $111M |
| Dec '21 | — | $4M | — | — | 2.7% | 2.3% | $8M | — | $109M |
| Sep '21 | — | $6M | — | — | 4.1% | 3.6% | $1M | — | $107M |
How the market has priced PETS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, PETMED EXPRESS INC's revenue has declined 10.2% per year. These are computed facts, not advice.
As of FY2026, PETMED EXPRESS INC reported — of total debt against $21M of cash.
In FY2026, gross margin was 28.1%, operating margin -32.8%, and net margin -32.0%.
As of Sep '26, PETMED EXPRESS INC traded at a price-to-earnings ratio of about 20.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.